Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial.

Authors

David Fitchett
Silvio E Inzucchi
Bernard Zinman
Christoph Wanner
Martin Schumacher
Claudia Schmoor
Kristin Ohneberg
Anne Pernille Ofstad
Afshin Salsali
Jyothis T George
Stefan Hantel
Erich Bluhmki
John M. Lachin, George Washington University
Faiez Zannad

Document Type

Journal Article

Publication Date

10-4-2021

Journal

ESC Heart Failure

DOI

10.1002/ehf2.13615

Comments

Online ahead of print

Recommended Citation

Fitchett, D., Inzucchi, S., Zinman, B., Wanner, C., Schumacher, M., Schmoor, C., Ohneberg, K., Ofstad, A., Salsali, A., George, J., Hantel, S., Bluhmki, E., Lachin, J. M., & Zannad, F. (2021). Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial.. ESC Heart Failure, (). http://dx.doi.org/10.1002/ehf2.13615

Peer Reviewed

1

Open Access

1